Cargando…

Dual antiplatelet therapy and drug eluting stents: a marriage of convenience

Detalles Bibliográficos
Autores principales:	Benezet-Mazuecos, Juan, Ibanez, Borja, Badimon, Juan J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082012/ https://www.ncbi.nlm.nih.gov/pubmed/17908311 http://dx.doi.org/10.1186/1477-9560-5-15

Ejemplares similares

Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?
por: Chang, Mineok, et al.
Publicado: (2014)

Perioperative management of antiplatelet therapy in patients with drug-eluting stents
por: Dimitrova, G, et al.
Publicado: (2012)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Hu, Mengjin, et al.
Publicado: (2022)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
por: Shen, Ying, et al.
Publicado: (2015)

Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better?
por: Huang, Qing-Yu, et al.
Publicado: (2015)

Perioperative dual antiplatelet therapy for patients undergoing spine surgery soon after drug eluting stent placement
por: Peeters, Sophie M., et al.
Publicado: (2021)

Risk Factors for Coronary Drug-Eluting Stent Thrombosis: Influence of Procedural, Patient, Lesion, and Stent Related Factors and Dual Antiplatelet Therapy
por: Sudhir, Krishnankutty, et al.
Publicado: (2013)

Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting Stents
por: Yoshikawa, Yusuke, et al.
Publicado: (2021)

Simultaneous Thrombosis of Two Drug-Eluting Stents After Discontinuation of Dual Antiplatelet Therapy for a Day
por: Chen, Hung Yi
Publicado: (2012)

Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
por: Kim, Sung Soo, et al.
Publicado: (2009)

Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a network meta-analysis
por: Gajulapalli, Rama Dilip, et al.
Publicado: (2017)

Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
por: Wang, Huili, et al.
Publicado: (2015)

Clinical outcomes of prolonged dual antiplatelet therapy after coronary drug-eluting stent implantation in dialysis patients
por: Park, Seokwoo, et al.
Publicado: (2020)

Impact of medication adherence to dual antiplatelet therapy on the long-term outcome of drug-eluting or bare-metal stents
por: Choi, Jung Min, et al.
Publicado: (2020)

Influence of dual antiplatelet therapy duration on neointimal condition after second-generation drug-eluting stent implantation
por: Goryo, Yutaka, et al.
Publicado: (2021)

Efficacy and safety of antiplatelet-combination therapy after drug-eluting stent implantation
por: Cho, Yun-Kyeong, et al.
Publicado: (2014)

Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
por: Geng, Xue, et al.
Publicado: (2020)

Long-term outcomes following drug-eluting balloon or thin-strut drug-eluting stents for treatment of in-stent restenosis stratified by duration of dual antiplatelet therapy (DEB-Dragon Registry)
por: Januszek, Rafał, et al.
Publicado: (2022)

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis
por: Kwok, Chun Shing, et al.
Publicado: (2014)

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
por: Barbarawi, Mahmoud, et al.
Publicado: (2019)

Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials
por: Tsoi, Man-Fung, et al.
Publicado: (2015)

Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stenting
por: Sim, Doo Sun, et al.
Publicado: (2019)

Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
por: Luo, Lin, et al.
Publicado: (2022)

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks
por: Zhang, Yong, et al.
Publicado: (2023)

Short versus long duration of dual antiplatelet therapy following drug-eluting stents: a meta-analysis of randomised trials
por: Rozemeijer, R., et al.
Publicado: (2018)

Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis
por: Yin, Shang-He-Lin, et al.
Publicado: (2019)

Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
por: Khan, Safi U., et al.
Publicado: (2020)

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
por: Gragnano, Felice, et al.
Publicado: (2022)

Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
por: Voudris, Vassilis, et al.
Publicado: (2014)

Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second‐Generation Drug‐Eluting Stents
por: Kim, Choongki, et al.
Publicado: (2020)

Predictors and Long‐Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug‐Eluting Stents (ADAPT‐DES) Intravascular Ultrasound Substudy
por: Wang, Bin, et al.
Publicado: (2016)

Impact of Dual Antiplatelet Therapy with Proton Pump Inhibitors on the Outcome of Patients with Acute Coronary Syndrome Undergoing Drug-Eluting Stent Implantation
por: Macaione, Francesca, et al.
Publicado: (2012)

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
por: Navarese, Eliano Pio, et al.
Publicado: (2015)

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
Publicado: (2016)

Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent
por: Vranken, Nousjka P. A., et al.
Publicado: (2022)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
por: Pivato, Carlo A., et al.
Publicado: (2022)

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial
por: Helft, Gérard, et al.
Publicado: (2013)

Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoing
por: Burlacu, Alexandru, et al.
Publicado: (2020)

Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis
por: Lee, Oh-Hyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u60qlipobqlclv9ahurel1v05c